On the routines of wild-type silk fibroin processing toward silk-inspired materials: a review by Volkov, Vadim et al.
ReviewOn the Routines of Wild-Type Silk Fibroin
Processing Toward Silk-Inspired Materials:
A ReviewVadim Volkov, Ana V. Ferreira, Artur Cavaco-Paulo*For years, silk fibroin of a domestic silkworm, Bombyx mori, has been recognized as a valuable
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approaches for silk downstream processing in a
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The detailed description of workflow possibilities
from the naturally found material to a finally
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tion is given to (bio-) chemical approaches of silk
fibroin transformation, particularly, to its enzyme-
driven modifications. The focus of the current
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wileyonlinelibrary.com1. Silk Fibroin, a Protein, and a Biopolymer domestication,[8] uses in textile industry and medicine.[7]Throughout the years of research a vast amount of
information concerning silk diversification is available.
Hence, the scope of the current review encompasses only
wild typefibrousprotein, andnot its genetically engineered
(chimeric) deviations ([1] and references within). Hybrid
materials, for instance, fibroin-based coatings on various
metal[2] and polymeric[3] supports or micro-fabricated
meta-material silk-metal composites[4,5] will not be dis-
cussed. Silk fibroin (SF) is a natural protein polymer,
producedby someof Lepidoptera species, suchas silkworms
and butterflies.[6] Depending on its source and biological
function, the silk composition, structure, and properties
may differ significantly.[7] One of the most characterized
silks come from the silkworm B. mori due to its history ofOwingtobiocompatibleandmechanicalpropertiesofSF, its
use has been increasing dramatically in biotechnology and
biomedical areas.[6] Attempts are being made to control
the silk fibroin-based technology from scratch and to
promote its up-scaling from the laboratory to industrial
scale, by developing methods and protocols suitable for
biotechnology and sustainable manufacturing.[9]
Wild-type silkworm SF, consists of two different
proteinaceous parts: the structural fibrous protein and
sericin, a glue-like protein that covers the fibroinmolecules
into larger fiber tread.[8] ‘‘Wild-type’’ protein in the
particular context is meant to be a naturally found (or
secreted), as opposed to the recombinant one.[10] Different
aspects of SF structure, composition, and MW have been
extensively discussed elsewhere.[11–17]
A number of SF structures have been reported (Figure 1
and see ref.[18]): the water-soluble state (Silk I), the
crystalline silk (Silk II), and an air/water interface
orientation (Silk III).[12] Silk I is ordinarily observed in
the silkworm glands,[19] it contains random-coil and
amorphous regions.[20] Silk I is unstable to mechanical orDOI: 10.1002/mame.201500179 1199
Figure 1. Schematic representation of the deduced SF structure. Insets show the fibril
overall structure and the fine b-sheet antiparallel alignment of SF polypeptide chains.
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1200shear stress,[8] thus it converts to antiparallel b-sheet, i.e.,
Silk II.[12] Iizuka and Yang have shown that Silk II structure
can also dissolvewithout precipitation inmixed solvents of
water and methanol or dioxane.[12,21] For the Silk II
structure, the antiparallel b-sheets, established by hydro-
gen bonds between the opposite Gly and Ala side chains
wereproposed.[8,12,22] The crystalline conformation leads to
a thermodynamically stable structure, preventing sponta-
neous separation of molecules[8] and water-based dissolu-
tion, including solvents of mild acid and alkaline compo-
sition, and some chaotropes.[12]
Finally, the crystal Silk III structure involves a hexagonal
arrangement of silk molecules in a threefold helical chain
conformation. This structure causes the separation of Ser
and Ala residues, allowing fibroin to act as a surfactant at
the air–water interface.[23]2. Manipulating Silk Fibroin: Initial
Processing and Physical Treatments of
Silk-Derived Materials
The current chapter describes various possibilities of silk
treatments that canbeperceivedasapreparationstep(s) for
its furthermodifications, or, insomecases, theycanresult in
a finally formulated product. Examples include, but are not
limited to, porous materials obtained by lyophilization,
or hydrogels acquired from gelation. Figures 2 and 3
summarize the main workflow routines, discussed below.2.1. Degumming of Silk Fibroin
As a starting point, the stifled cocoons (devoid of pupae)
need to be de-gummed. The degumming process is a sericin
coating removal and results in cocoon decomposition, raw
silk fiber mass is obtained. Several ways of degumming
have been reviewed before,[24,25] of which boiling in 0.02M
sodium carbonate, Na2CO3, for 30min is commonly
used.[26] Recently, the use of a recombinant cocoonase
enzyme fromB.mori source (BmCoc) in the silk degumming
processwasreported.[27] Sericin removalpursues twogoals:
it abolishes biocompatibility issues of subsequent silkMacromol. Mater. Eng. 2015, 12, 1199–1216
 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheapplications and exposes the fibrous
molecules for further processing options.
Sericin is immunogenic,[28,29] but SF
protein per se is not.[30] SF is approved
by the American Food and Drug Admin-
istration (FDA) as a source for biomate-
rials production.[20] Nevertheless, degum-
ming affects the fibrous protein by
altering its mechanical properties like
elasticity and tensile strength[31] via
modified molecular structure.[32] Further
studies showed that fiber MW[33] and therelatedviabilityof cells, cultivatedonSF-basedmaterials[34]
are also affected. Prolonged degumming in harsh con-
ditions results in degradation of SF into lower MW
fragments influencing cell functioning. Considering this,
possible side effects of different degumming protocols
should be taken into account when designing a biocom-
patible material.2.2. Introduction to the Processing: Modifications of
Intact Silk Fiber
Sericin-free silk can be used directly, in a solid state, or
preferably be dissolved, as an initial step of material
fabrication. SF can be used directly for fabrication of
tetracycline-loaded sutures,[35] cross-linked silk-colla-
gen,[36] and silk-gelatine[37] scaffolds, poly lactic-co-glycolic
acid (PLGA)-coated and bFGF-releasing bio-hybrid materi-
als,[38] twisted silk cords[26] or silk-based hollow tubes.[39]
The common aspect of these approaches is the preparation
of braided, knitted, or yarned fibrous structures that serve
as a frame for further production. In some cases, this frame
of future material can be elaborated prior to degum-
ming,[40,41] still most of all the subsequent treatments are
performed after sericin removal step. Bromination[42] and
chlorination[43] of SF fabrics on Ser residues with halogen
derivatives were reported, with yields of Ser conversion of
10 and 30%, respectively. Raw silk filaments can also be
modified by the nano-TiO2 and chitosan dispersion system
via cross-linking reactions of citric acid and maleic
anhydride.[44] Modified SF-exhibited rougher surface and
increased crystallinity than that of the original fibroin,
while the fundamental crystal structure remained intact.
UV irradiation is anotherway of altering SF—it can be used
as modeling of ageing processes within the biopolymer by
Tyr photo-oxidation and cross-linking of Tyr and other
residues[45] (Figure 4). Additional morphological effects,
seen as roughening, were observed on the surface of
irradiated silk samples.[46,47] The roughening, caused by
forming of nanopores, was accompanied by slight degra-
dation and decrease in mechanical properties. Aspects of
free radical formation in SF were further elucidated by
electron spin resonance (ESR) studies.[48] Silk fabrics,im www.MaterialsViews.com
Figure 2. Outline of the main steps in possible silk pre-treatment protocols. In this context, the ‘‘pre-treatment’’ means any procedures,
aiming to prepare the raw fibrous material for a downstream processing. The key points are raw silk fibroin in its cocoon form and the final
product. Underlined phrases designate (intermediate) products. Arrows designate the workflow direction. Example images of raw silk and
final product are not to scale. Methods designated by asterisk are the scope of extended revision and are depicted in Figure 3.
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www.mme-journal.deoxidized by ozone, displayed increase in yellowness,
moreover, a decrease in breaking strength and elongation,
weight, and flexibility was noticed.[49] LBL polymers of
poly-(allylamine hydrochloride) and poly-(acrylic acid),
deposited on SF fabrics, were further enhanced by cross-
linking with activated heparin. By doing this, the hemo-
compatibility of the resulting material was improved.[50]2.3. Fibroin Dissolution Techniques
The more promising and common way of using SF in
material engineering is through itsdissolutionandworkingMacromol. Mater. Eng.
 2015 WILEY-VCH Verlag Gmwww.MaterialsViews.comwith solubilized fibroin. Due to its tightly packed structure,
SF is insoluble in most solvents, used to dissolve polymers
for biological applications, and inwater. To dissolve SF, two
main concentrated salt-based systems are employed: non-
aqueous and aqueous. The first includes calcium nitrate in
methanol, Ca(NO3) 2–MeOH;[51] lithium bromide in etha-
nol, LiBr–EtOH;[52] calcium chloride in formic acid,
CaCl2–FA;[53] compounds of methylimidazolium group
(so-called ionic liquids), [54,55] and some others. Those
acquired solutions are further utilizedwithout dialysis. The
second, water-based, system encompasses lithium or
sodium thiocyanates, Li- or Na-SCN;[56,57] lithium bromide,2015, 12, 1199–1216
bH & Co. KGaA, Weinheim 1201
Figure 3. Detailed representation of the three (pre-) treatment directions for silk fibroin:
physical, chemical, and enzymatic. Arrows designate different processing options. For
detailed description, see text.
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1202LiBr[26] or salts with similar nucleophilicity of the anion.[58]
Special cases may dictate the usage of cuprammonium
hydroxide (cuoxam), for example,whenSF/cellulose blends
are prepared.[59] Ternary aqueous systems of calcium
chloride or lithium bromide and ethanol CaCl2/LiBr–
EtOH–H2O[60,61] are also known. The dissolution step is
followed by a dialysis in water/appropriate buffer for salt
removal. For water-based system, a 9.3M aqueous LiBr at
60 8C, 4 h incubation is typically used.[26] Moreover, some
organic systems with residual water content are known,
similar to N-methyl morpholine N-oxide (MMNO) hydrate,
where the water significantly influences the ability of the
compound to act as a solvent.[62] Whether prepared from
aqueous or non-aqueous solution systems, the finallyMacromol. Mater. Eng. 2015, 12, 1199–1216
 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheielaborated materials are considered as
obtained from regenerated silk fibroin
(RSF).2.4. Initial Processing. The
Handling of an RSF Solution Fibroin
With the RSF being at stock, a workflow
can generally be split in three direc-
tions: freeze-drying and working with
lyophilized material, solution alteration
(either physically, chemically, or both),
or its direct subsequent processing.
The latter option means that an RSF
solution is used ‘‘as is’’ in the down-
stream application, whilst the first two
approaches imply some preceding step-
(s) before RSF use in that successive
application. Direct processing is com-
prised of RSF coatings of previously
elaborated materials, either by layer-by-
layer (LBL) method or simple soaking
(reviewed in refs.[63,64]); blending with
other compounds of interest, including
their bulk loading, as reviewed in ref.[65]
Mineralization of prepared silk-based
scaffolds by rounds of calcium phos-
phate (apatite) deposition is also possi-
ble.[66–69] Recently, the effects of differ-
ent foetal bovine serum (FBS) types on
mineralization of 3D silk-based scaf-
folds were elucidated. Dependent on
FBS type, spontaneous mineralization
was observed in some scaffolds.[70]
Other alternatives include dipped or
spun silk tubes and vortexed hydrogels,
those preparations are detailed in ref.[26]
Metastable silk nanoparticles, prepared
by repeating drying–dissolving process
of aqueous RSF solution, are alsoavailable.[71]
Freeze-drying may be used as a final product formula-
tion,[72,73] however, usually is used as an intermediate step.
Hence, the lyophilized RSF can be later re-dissolved in
various solvents like hexafluoro-2-propanol (HFIP), hexa-
fluoro-acetone (HFA), formic, or trifluoro-aceticacids, for the
fabrication of (electro-) spunnanofibers, scaffolds, or casted
films.[74–77] Some 3D scaffolds (or sponges) can be produced
with the help of introduced porogens (typically NaCl with
subsequent salt leaching[78,79]), or with the help of
modulators for a forming fine structure conformation
like glycerol,[80] or fabric reinforcing technique[81] and not
solely by freeze-drying. At the stage following re-
dissolution, RSF is often blended with other compoundsm www.MaterialsViews.com
Figure 4. Proposed pathways of tyrosine photo-oxidation. (A) Variety of final products.
(B) Specific pathway toward dimerization (via C—O or C—C linkages) to yield di-tyrosine
product. 1—tyrosyl radical, 2—a C–O linked isomer of a di-tyrosine cross-link. Images
adapted from refs.[45] and, [224] respectively.
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www.mme-journal.deof interest; the final material formulation depends on the
current need. Similarly to the direct processing and after
the formulation, SF-derived devices may be coated by
simple deposition of molecules of biological significance
like vascular endothelial growth factor (VEGF) and/or
laminin,[82] BMP-2.[83] Numerous examples of RSF-based
scaffolds,[84] blended[85,86] and regenerated[87,88] films,
and spun nanofibers,[89] along with their features and
fabrication methods, have been reported. The reason why
raw SF is not exposed for dissolution directly by some
solvents (especially organic: HFIP, HFA) stems from the
fact that fibroin can be efficiently dissolved only after its
preliminary activation.[58] Such activation is the process
of silk primary dissolution by near-saturated solutions of
chaotropes, as described before. For instance, attempt to
dissolve raw-degummed SF in HFIP took 5 months for its
completion.[90]2.5. Advanced Processing. Treatments of an RSF
Solution and RSF-Derived Materials
Solution alteration treatments, mentioned in the previous
part, actually open an immense field of possibilities for
material design and development and thus demand a
special description. The treatments can roughly be divided
in two: physical and chemical, that are a minor and major
part of all possibilities, respectively. In turn, the chemical
modifications can be traditional, non-enzymatic, reactions,
or be catalyzed by enzymes. For the summary of methods,
presented below, refer to Figure 3. Chemical modifications
will be discussed separately in the next chapter.Macromol. Mater. Eng. 2015, 12, 1199–1216
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manipulations, applied to RSF solution,
aim three goals—hydrogels production
(gelation), induction of aqueous insolu-
bility of elaborated materials, or sterili-
zation. Gelation is commonly induced
by shear stress (vortexing),[91] mild son-
ication[92] (also possible in combination
with other natural polymers like chito-
san[93] or agarose[94]), or elevated temper-
ature.[95] Kþ or Ca2þ ions addition also
facilitates hydrogel formation at
decreased pH of RSF.[92,95] Polyethylene
oxide (PEO), [95] poloxamer 407,[96] poly-
alcohols (glycerol, polyethylene glycol,
and similar compounds[97–100]), sodium
dodecyl sulfate (SDS)[101] additives are
known as gelation promoters. Due to
their hydrophilicity, PEO, poloxamer 407,
and polyalcohols dehydrate RSF, causing
its hydrophobic self-aggregation, while
sodium dodecyl sulfate (SDS) causes RSF
to form mixed micelle particles. ThoseSDS/RSFmicelles serveasnucleationcenters for subsequent
hydrophobic agglomeration of silk. Gel formation may
also be promoted by increasing silk concentration in
solution.[92,102] Recently, CO2-assisted synthesis of RSF
hydrogels by gas bubbling and 3D, 2D, or standalone RSF
structures by electrohydrodynamic (EHD) bubbling were
reported.[103,104]
The virtual insolubility of (R)SF-derived materials in
aqueous media is a crucial property at the end of
production, since in most cases their application will
involve contact with water or water-based solutions. It
is directly related to crystallinity of a fibroin. Common
practices of crystallinity induction include methanol
treatments[105–107] or increased temperature applica-
tion[106] (both done for already produced materials) and
altering of ionic balance[95,108] (for the ‘‘liquid step’’ of
a fabrication; casted material will be water-insoluble
upon solvent evaporation). However, saturated salt sol-
ution may be also used for crystallinity augmentation
of prepared, dry product formulation, as silk micro-
spheres.[109] Shear stress during SF spinning in the glands
of insects[110] may bemimicked to some extent ex vivo and
spun silk fibers, bearing characteristic silk II structure, may
be obtained.[111] Sometimes the above-described means
for rendering materials that are water-stable are less
preferable. Water vapor annealing[112–114] and gradual
freezing (with or without lyophilization)[115,116] represent
milder conditions for the same purpose.
It can be seen that such treatments as temperature
augmentation and lyophilization, despite their difference,
can serve two goals, relying on mechanistically closeheim 1203
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1204phenomena—complete or partial gelation and decreased
solubility in aqueousmedia. In this context, it is interesting
to mention that sterilization, generally performed on
formulated material,[117,118] may be applied to RSF sol-
utions. As reported, autoclaving of RSFs of varying
concentrations (4, 8, and 12% w/v) ‘‘did not significantly
change the sonication parameters used and the related
gelation times.’’[92] Several reports assess the possibilities
for sterilization of SF-based materials. Methods like
immersion in 70% ethanol solution, autoclaving (steam),
ethylene oxide (EO), ultraviolet (UV) or g radiation
application, dry heat and antibiotics mix wash were
investigated. Studies agree that autoclaving considerably
affects mechanical properties of silk, whilst EO has very
little influence.[119–121] Eventual darkening of steam-
sterilized silk was observed.[121] Recent examination
confirms the time-dependent thermal degradation and
partial conformational changes of silk structure in the
course of autoclaving.[122] Ethanol had adverse mechanical
effects on differently formulated materials,[120] but is not
considered as appropriate sterilization agent, but rather
a disinfection mean.[119] Both UV and g irradiations
retained the original conformational structure of elabo-
rated devices,[120,121] whereas g radiation caused silk
degradation in a dose-dependent manner.[121] Similarly
toethanol,UVwasconsideredawayofdisinfection.[120]Dry
heat caused partial destruction and shrinkage of porous
scaffolds, while antibiotics mix caused no effect.[119]
Interesting outcomes were obtained when RSF cast films
were subjected to electron beam irradiation at a dose
range between 0 and 150 kGy.[123] Along with changes in
crystalline structure and thermal stability, antibacterial
activity of films against both gram-positive and -negative
bacteria has increased. The reported increase was dose-
dependent. Summarizing, sterilization is another impor-
tant aspect in the total workflow of silk-based materials
production, and some sterilization methods may serve
additional goals as crystallinity and water-insolubility
inductions.3. Manipulating Silk Fibroin: Chemical and
Biochemical Approaches of RSF
Functionalization
Chemical ways of treating silk represent additional and
optional level of complexity that may be employed during
production, if necessary. Inmost cases, the researcheswish
to customize a final product, rendering (bio-) chemistry as
indispensable. Chemical approaches applicable to RSF can
be roughly divided into three categories: surface modifica-
tion only (leaving thematerial bulk intact), modification of
entire material (typically in the pre-formulation stage),
and the sonochemical methods. Biochemical approachesMacromol. Mater. Eng. 2
 2015 WILEY-VCH Verlag GmbHconstitute surface or bulkmaterialmodifications. The third
chapterpresentsadetailedoverviewof theaforementioned
statements. Figure 3 summarizes the main workflow
routines, discussed below.3.1. Chemical Approaches
Surface modification includes gas plasma treatments
for tailoring hydro–phobicity or hydro–philicity,[124]
improving cytocompatibility,[125] and modulating cell
attachment.[126] It was postulated that the ionized plasma
particles are incapable of penetrating into the depth of
textile materials.[127] A sophisticated system, where RSF
films are initially aminated by ammonia, NH3 and later
covalently sulfonated by sulfur dioxide, SO2 plasma treat-
ments was reported.[128] UV irradiation can be used for
conferring hydrophilicity to RSF-based films.[129] Recently,
UV-mediated cross-link blends of RSF and chitosan were
reported.[130]
Other strategies, described below, are applicable to both
solid and aqueous forms of SF. A research by Sofia et al.[131]
on functionalization of SF-based material with peptides
or proteins of interest by means of 1-ethyl-3-(dimethyl-
aminopropyl) carbodiimide (EDC)/N-hydroxysuccinimide
(NHS) coupling chemistry was later highly exploited for
decorating films and matrices[132–135] and porous scaf-
folds[136] with Arg–Glu–Asp (RGD, cell adhesion receptors
recognition) sequence. Additional examples, amongmany,
include the production of composed elastin/silk/hyalur-
onan materials,[137] immobilization of Horseradish perox-
idase enzyme on the surface of scaffolds[138] or solubilized
fibroin attachment to poly(d,l-lactic acid) made films.[139]
The approach relies on covalent bond formation between
activated g-carboxylic groups of Asp and Glu in SF and a
primary amine target, typically e-NH2 group of Lys.
[140]
Together Asp and Glu constitute 1% of all fibroin
molecule’s amino acids, yet also 0.23% of Lys is present
in the polypeptide chains,[14] so that SF self-cross-linking
by-products may be formed along with the intended
conjugates. The same statement is true regarding any
polypeptide to be coupled, possessing both free carboxylic
and amino groups, yet this issue is for most disregarded in
the cited examples of the previous paragraph, except for
one.[138] Other potentially unwanted effects may be
introduced to the molecules being coupled via EDC/NHS
reaction,[141] like alteration of net charge, conformation, or
activity (in case of enzymes).
In spite of the mentioned difficulties, chemical mod-
ifications of SF solutions or surfaces of formulated SF-
based solid devices, based on carbodiimide chemistry, are
quite common. Yet, to overcome some of the drawbacks, a
copper (I)-catalyzed azide–alkyne cycloaddition (CuAAC,
commonly referred to as ‘‘click chemistry’’) was proposed
for SF enhancement[142] (Figure 5). Other coupling015, 12, 1199–1216
& Co. KGaA, Weinheim www.MaterialsViews.com
Figure 5. Reaction scheme detailing the synthesis of SF conjugates with the molecules of interest by (A) CuAAC or (B) EDC/NHS chemistry.
Figure taken from ref.[142]
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www.mme-journal.depossibilities are known, for instance cyanuric chloride-
assisted attachment of preliminary activated PEG mole-
cules,[143] lactose derivatives,[144] and N-acetyl-chito-oligo-
saccharides[145] to the Tyr side chain of silk (Figure 6). 2-
Methacryloyloxyethyl isocyanate (MOI)-assisted addition
of terminal vinyl groups to OH- NH2- and COOH- bearing
amino acids side chains, followed by the grafting of 2-
methacryloyloxyethyl phosphorylcholine (MPC) is also
known[146] (Figure 7). The aim of the above-mentioned
approach is toderivatize silk fabric, decreasing theadhesion
of blood platelets. In that sense, a non-thrombogenic
material can be elaborated. Moreover, genipin- andFigure 6. Chemical modification of SF with cyanuric chloride-activat
Figure 7. Chemical modification of SF with cyanuric chloride-activate
Macromol. Mater. Eng.
 2015 WILEY-VCH Verlag Gmwww.MaterialsViews.comglutaraldehyde-assisted linking reactions of elastin[147]
and insulin,[148] respectively, to the silk fibroin were
described (Figure 8). Using genipin, silk molecules can be
cross-linked with hydroxybutyl chitosan, thus improving
the mechanical properties of the resulting material and
rendering it less cytotoxic.[149] Blended SF–starch–chitosan
matrixes, using a non-toxic conjugation method of
reductive alkylation chemistry, were successfully prepared
and showed high cytocompatibility toward Sarcoma
osteogenic (SaOS-2) cells.[150] Cell proliferation could be
modulated by changing fibroin/chitosan ratio during the
matrix preparation.ed oligosaccharides. Figure adapted from ref.[144]
d oligosaccharides. Figure adapted from ref.[144]
2015, 12, 1199–1216
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Figure 8. Cross-linking reaction of genipin with biopolymers containing free amine groups.
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1206In addition to Tyr, direct modifications of particular
amino acids, constituting silk fibroin chain, are possible. As
such, chemicallymediated Argmasking and enzymatically
mediated Ser phosphorylation and Tyr oxidation are
known. Arg masking is the positive charge screening of
this amino acid by modification of its side chain with 1,
2-cyclohexandione under basic conditions. The stability of
the formed imidazolidinone reactant, bearing negative
charge, depends on reaction conditions.[151,152] The latter
option, however, does not receive much attention possibly
due to the lowamountsofArgpresent in silk. Enzymatically
mediated reactions are discussed in the next chapter.
Moreover, Tyr sulfonation can be performed by various
ways. Gas plasma treatment, mentioned above, offers one
possibility. Another method is to use chlorosulfonic acid in
pyridine solution[153] (Figure 9). Sulfonation aims to impartFigure 9. Proposed mechanism for the pyridine-assisted Tyr side cha
chlorosulfonic acid.
Macromol. Mater. Eng. 2
 2015 WILEY-VCH Verlag GmbHanti-coagulant and anti-thrombogenic activity of SF-
derived materials; the second treatment resulted in the
modification of both Tyr and Ser side chains. Developments
of the second method were lately reported. Electrospun
sulfated SF nanofibrous materials and PLGA scaffolds with
covalently immobilized sulfated silk for vascular tissue
engineering purposes have been fabricated.[154,155] Recent
work explored the feasibility of direct silk sulfonation,
dissolved in the 1-butyl-3-methylimidazolium chloride
([BMIM]Cl, an ionic liquid).[156] Milder reaction conditions
andhence lower silkdegradationwere found tobe themain
benefits of the presented protocol.
The last possible working direction to be mentioned in
this part is a sonochemical approach, i.e., ultra-sound-
assisted fabrication of nano- or micro-particles (spheres)
from SF. In sonochemistry, the reacting molecules undergoin sulfonation by
015, 12, 1199–1216
& Co. KGaA, Weinheima chemical transformation owing to the
utilization of powerful ultrasound radi-
ation (20 kHz–10MHz).[157] It was postu-
lated that no direct interaction at molec-
ular level between the ultrasound and
chemical species exists. Yet, chemical
effects of ultrasound are exerted by an
acoustic cavitation, in turn driven by
high-intensity ultrasound.[158] Ultra-
sonic irradiation of aqueous solutions
generates highly reactive species like
hydrogen (H•) and hydroxyl (•OH)www.MaterialsViews.com
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www.mme-journal.deradicals.[159] In thecaseofpresenceofoxygen,hydroperoxyl
radicals (HO2•) can also be generated. These highly reactive
intermediate products are used in different sonochemical
reactions. SF-derived particles, produced by ultrasonic
emulsification, possess high stability, low toxicity, and
are found compatible as ‘‘drug carriers.’’ Their sizes range in
the interval between 500 nm–1.5mm, what ascribes them
to both nano- and micro-scale of the produced struc-
tures.[160] Currently, there is amodest number of examples
for the silk-derived materials, formulated by ultrasonica-
tion. Our group reported on both bovine serum albumin
(BSA) and SF-basedmicrospheres, formed by high-intensity
ultrasound.[161] BSA secondary structurewas not disturbed
during the microsphere synthesis, but an increase in the
b-sheet content for silk was detected. A patent describing
particular conditions for silk microspheres production was
published.[162] Recently, SF-based hydrogels, acquired by
sonication, were used to deliver the therapeutic Bevacizu-
mab, achieving sustained release for an in vivo animal
system.[163] An interesting system of nano- and micro-
fibers production by sonication-controlled hydrolysis of
raw-degummed fibroin was recently presented.[164] The
acquired degradation products had an MW of less than
20 kDa in general and possessed alternated surficial and
structural properties, comparing to the starting material.
In some cases, sonication is used for the purposes of
dispersion of already formed microspheres from the bulk
phase.[109,165,166] Much bigger spheres (up to 440mm)
can be produced by laminar jet break-up of aqueous SF
solutions, induced by a nozzle, vibrating at a controlled
frequency and amplitude.[167] Moreover, sonication facil-
itates the phase separation of silk/poly-vinyl alcohol (PVA)
blends to generate stable microspheres.[168] Stability
increased with augmentation of sonication amplitude
and it correlated with increased b-sheet structures for-
mation in SF. In the two latter cases, however, no sono-
chemistry per se is involved. A handy protocol compen-
dium, describing various productionmethods of silk-based
devices, including microspheres, is available.[26]3.2. Biochemical Approaches
Biochemical (i.e., enzymatic) approaches will be the final
part of the current review. In the last decades, numerous
attempts were made to substitute the ‘‘conventional,’’
purely chemicalmethods, by amore environment-friendly,
the so-called ‘‘green chemistry’’ techniques. In that extent,
enzymatically driven reactions attract significant atten-
tion, not only for being relatively non-hazardous or harsh
treatments, but also due to their high specificity toward the
substrates. The latter, however, is the source of their
relatively low reaction yields, when compared to regular
chemistry procedures. Moreover, as any proteinaceous
molecule, theenzymes typically suffer fromstability issues,Macromol. Mater. Eng.
 2015 WILEY-VCH Verlag Gmwww.MaterialsViews.comwhat limits their application. We now shall focus on the
reported examples of enzymatic treatments of fibrous
materials.
Enzymatic treatments of SF commonlypursue twogoals:
its (selective) degradation or its conjugation with other
polymers. Some chemical andmechanical properties of silk
can be adjusted toward specific needs by the targeted
degradation. For instance, b-sheet content of cast SF films,
tuned by protease XIV and a-chymotrypsin, demonstrated
suitability of themethod for the construction of temporary
corneal stroma tissue for corneal tissue regeneration.[169] SF
yarns, treated with the same enzymes, made it possible to
establish the in vitro degradationmodel system, important
for the mechanical and structural studies of fibrous
materials.[170] Another study, aiming similar purpose,
was conducted on a spongy, porous SF sheets, partially
cleaved by protease XIV, a-chymotrypsin, and collagenase
IA.[171] It has also been established that protease XIV
was the most effective, against specific material type,
while a- chymotrypsin was the least effective. SF powders,
pre-treated with proteinase K, demonstrated a porous
network structure, when formed by a co-precipitation
methodwithhydroxy-apatite solution.[172]Moreover, some
important implications of the treatment, like overall
structure 3D crystallization growth, were detected. Selec-
tive and usually milder degradation of SF-based materials
can be used for their further diversification. As such,
proteolytic cleavage of the amorphous regions in SF
solution by a- chymotrypsin leads to phase separation.
Self-assembly of remaining regions into silk microgels
was reported; the gels possessed a negative charge, were
highly crystalline, and porous.[173] For those microgels, the
cationic drugs delivery system may be proposed. A
comprehensive analysis on SF degradation rates and
degradation-related products, originating from different
cleavage pathways, was presented. Biocompatibility
related issues that are the function of degradation type
(‘‘natural’’ or ‘‘unnatural’’) were observed and dis-
cussed.[174] Efficient degradation of fibroin by a thermo-
phile B. thermoruber[175] and a comparison between acid-
mediated and various proteolytic enzymes hydrolyses of
fibroin were reported.[176] Additional cases of SF enzyme-
mediated degradation were reviewed.[20] An interesting
study of sterilization means impact on enzymatic degra-
dation and mechanical properties of silk-derived porous
scaffoldswasconducted. Structural rearrangements, result-
ing from autoclaving, affected the degradation and
mechanical properties, but not ethanol sterilization that
caused mild crystalline structure alterations.[177]
Enzymatic grafting of biomolecules like chitosan and
lactoferrin was reported. Several works describe the
conjugation techniques of chitosan,[178–181] whilst only
one recent study talks about bovine lactoferrin graft.[182] In
the first case, a mushroom tyrosinase (MT) is utilized to2015, 12, 1199–1216
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Figure 10. Selective oxidation of SF by MT enzyme and the subsequent grafting of
chitosan onto oxidized silk. Figure adapted from ref.[181]
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1208oxidize Tyr residues to electrophilic o-quinones. The
formation of o-quinones is a determining step in the
overall grafting reaction. Moreover, accessible tyrosyl
groups that can be oxidized by MT, belong to the more
solvent-accessible segments of SF chain; steric hindrance
factors shouldbe taken into consideration. Subsequently,o-
quinones reactnon-enzymaticallywithnucleophilic amino
groups of chitosan by Schiff-base and Michael addition
mechanisms (Figure 10). Chitosan grafting provokes con-
siderable changes in the thermal behavior of SF, caused by
b-sheet ! random coil conformational transition. Due to
the hardness of the conjugated materials, they may be
utilized in the applications of elevated stiffness such as
scaffolds. For lactoferrin grafting, silk fabrics are also
treated with MT and the protein of interest is later added.
Lactoferrin is an iron chelater, what contributes to its
bacteriostatic ability. Furthermore, lactoferrin can interact
with the bacterial cell membrane and make it lose its
barrier function. In the reportedwork, lactoferrin-enhanced
silk fabrics showed ‘‘encouraging’’ bacteriostatic activity
against the gram-positive and -negative bacterial species.
Additional approaches to functionalize silk are com-
prised of two more strategies of preparing fibrous
polymeric structures (hydrogels and segmented block co-
polymers), enzymatically driven mineralization of silk
scaffolds, and in vitro phosphorylation of SF. Horseradish
peroxidase (HRP)/hydrogenperoxidesystemwaspresented
as ameanof fabricating SFhydrogelswith tuneableb-sheetFigure 11. Example of synthesis procedure of Zn (II)-poly(acrylonitrile-co-SF) complex. Fig
Macromol. Mater. Eng. 2015, 12, 1199–1216
 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheicontent. Gels, initially elaborated with
random-coiled structure (silk I or amor-
phous) converted to b-stacks after pro-
longed (7 d or more) exposition to the
surroundings. Attempt of human malig-
nant cell lines (HeLa, U251) cultivation
was made; a growth inhibition of both
lines was detected.[183]
A series of data regarding poly-
(acrylonitrile-co-SF peptide) syntheses
was previously divulgated. The common
strategy was to co-polymerize acryloni-
trile (AN) with a vinyl-decorated SF
peptide (Figure 11). The peptides were
acquired by enzymatic digestion of SF
powder by a- chymotrypsin and subse-
quently reacted with acryloyl chloride in
appropriate solution. To obtain the
final products, polymerization with ANwas carried out. One article described various possible
AN-containing formulations, obtained by random co-
polymerization, graft-polymerization, and blended mate-
rial type.[184] In thenextpaper, segmentedblockco-polymer
was enhanced during the course of its synthesis by zinc
ions, between the acylation phase with acryloyl chloride
and the final ANco-polymerization. The obtainedmaterials
exhibited good odor-removing and antibacterial proper-
ties.[185] The last work combined all aforementioned
methods with a wet-spinning process, thus fabricating
poly(acrylonitrile-co-SF peptide) fibers.[186]
Alkaline phosphatase (ALP)-assisted in situ mineraliza-
tion of pre-fabricated SF-based porous scaffolds was
reported. Electrostatic attractions between ALP and SF
scaffolds anchor the enzyme. Later, provided with miner-
alization medium (mixture of glycerol phosphate calcium
salt and calcium phosphate salts), deposition of mineral
calciumphosphatewasobserved[187] (Figure12). Researches
also elucidated the relationship between mineralization
degrees and osteoblast cell line responses that was
inversely correlated. In this particular case, although the
fibroin was not modified directly by the enzyme, the
mineralization would not be possible without ALP.
Lastly, in vitro enzymatic phosphorylation of specific
amino acid, Ser was reported. Since the pioneering work of
Winkler et al.,[188] it was further developed by our group.
Winkler and co-workers successfully phosphorylated
genetically engineered spider silk with protein kinase Aure taken from ref.[185]
m www.MaterialsViews.com
Figure 12. Proposed reaction mechanism of ALP with calcium phosphate. Figure taken from ref.[187]
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www.mme-journal.de(PKA), presenting the possibility to enzymatically modify
fibrous materials in a particular way. Our findings on
processing the wild-type mulberry silk demonstrate the
following[189,190]: (a) this silk, when appropriately dis-
solved, can undergo in vitro enzymatic phosphorylation;
and (b) phosphorylation allows to tune various chemical
and physical properties of silk,what can be used for specific
applications. Although the phosphorylation levels were
quite low (Figure 13), those impose strong effects on
structural conformation of SF (lesser b-sheet content) and
increased hydrophilicity, accompanied by augmentation
of negative charges at physiological pH. In that context,
it is worth noticing that the outcomes of cell cultur-
ing[183,189,191–193] indicate that conformation transition
within silk, aswell as surface properties, are responsible for
cellular attachment/proliferation. Thus, if a silk as bio-
material of choice is used and treated by the ‘‘green’’
method, its properties can be tuned and the issues of
biocompatibility can be avoided or considerably alleviated.4. Formulated Products From Processed RSF
Until now, our description was mainly concentrated on
the means of RSF diversification, without special accent
given to processing/formulation aspects. Different finalFigure 13. The representation of predicted phospho-sites in silk fibro
predicted in silico, others by sequence analysis of protein kinase A con
present in the protein, are depicted. Those include the N-terminal a
(shown as thick lines). Figure adapted and reproduced with permiss
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 2015 WILEY-VCH Verlag Gmwww.MaterialsViews.comformulations (films, scaffolds, hydrogels, etc.), although
mentioned, had a subordinate importance. Notwithstand-
ing, it is no less important to state those processing options
leading to a final product form. Figure 14 summarizes
the following chapter.
Films (or mats) of varying mechanical and structural
properties can be obtained by solvent casting of RSF
solutions. At solvent evaporation phase by controlling
environment conditions, such as temperature, pH, and the
physical amounts of the poured solution, final stiffness
may be tailored.[190,194] Desired surface topography is
determined by the used molds of a pre-designed form;[194]
moreover, enhancing stress and strain is performed by the
stretching of a dried material.[195] The composition of
source RSF solution may influence the fine structure of
elaborated films, for instance, SF films cast from formic acid
appear to be more crystalline than their water-derived
counterparts.[77]Onthecontrary,decreasedb-sheet content
coupled to water insolubility was achieved by decreasing
the drying rate of RSF solution.[196] A development of the
latter method was published, where films, prepared by
slow drying process, were rehydrated and subsequently
stretched.[197] The increased content of bound water was
thought to impose a plasticization effect, resulting in
more flexible and prone to degradation product, yet water-
insoluble.in. The sites, resulting from different prediction methods (asterisks,
sensus motif), are indicated by thin lines. The major segment types,
cidic and C-terminal basic domains and 11 ‘‘amorphous’’ sequences
ion from 2015 WILEY-VCH Verlag GmbH & Co.[189]
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Figure 14. A variety of silk-basedmaterials, formulated from RSF. Note: SF particles could
also be acquired from the raw-degummed fiber, and not only from the regenerated silk
solution.
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1210Another way of producing silk mats and nanofibers is
electrospinning. Activated, i.e., previously dissolved silk
(typically stored in dry form) is re-dissolved in FA or
HFIP-containing solutions and supplied to the electro-
spinning system.[74,198,199] By changing starter solution
(protein concentration content, helper chemicals, and other
blended compounds of interest), different aspects of the
finally produced materials are governed.[74,199]
Hydrogels, that may be used for mimicking the aquatic
environment in vivo, are obtained from RSF aqueous
solutions. The naturally present tendency of solvated silk
molecules for hydrophobic self-aggregation[200] is
exploited in several methods, that include, but not
limited to, the elaboration of composite SF and nano-
hydroxyapatite (HA) gels,[201] hydrogels and lyogels,[202]
nanofiber hydrogels,[203] reinforced hyaluronan–silk
hydrogels.[204] In the listed examples, EtOH, sonication
and subsequent lyophilization and slow concentration–
dilution process were used as gelling agents. The last
method, however, included SF electrospinning as mean
of hard support production, on which the hyaluronan-
based gel was later mounted. All of the above materials
demonstrated biocompatibility[201,203] or controlled
release of the incorporated therapeutic molecules.[202,204]
Further developments of RSF gelation via dehydration by
dialysis against MeOH or via nanofiber preliminary
formation in regenerated aqueous silk solution were
reported.[205,206] Interestingly, in the last work sonication
was used to transfer the prepared hydrogel to solution.
Silk nanofibers, formed by a slow concentration–dilution
process of silk solution, ruptured under ultrasonic treat-
ment, thus making hydrogelsolution transition
possible.
Foams for regenerative or supporting medicine applica-
tions were reported. Those foams were injectable and
obtained either by freezer-processing[207] or polyethylene
glycol (PEG)-based gelation[208] techniques. The firstMacromol. Mater. Eng. 2015, 12, 1199–1216
 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheimethod is actually a lyophilization proc-
ess, preceded by mild freezing that
determines thefinestructuralandhydro-
philic features of the formed device. The
secondapproach relies ondehydrationof
a fibroin in the presence of more hydro-
philic PEG polymer. Lyophilization-
obtained foams were utilized, among
other, in filling soft tissue defects in a rat
model, while PEG-containing foams
were examined for an alternative to
cervical cerclage therapy.
Rods (or microtubes) and micronee-
dles (MNs) of several diameters and
shapes can be fabricated for different
purposes. As such, formulated silkmicro-
tubes, either porous or continuous for amicrovascular replacement applications[209] and reservoir
rods for long-term sustained drug delivery[210] are known.
Rods and microtubes were done by dipping steel wire into
SF solution with subsequent MeOH application, or by
injection of silk feeder solution through a narrow gauge
needle onto a steel wire following heat treatment,
respectively. The latter method is termed ‘‘film-spinning.’’
Both MeOH and heating treatments aimed to induce
material crystallinity and confer resistance to the contact
with aqueous environment. The porosity of themicrotubes
was controlled by blending ratios of SF/PEO, following the
extraction of PEO in water. Increased concentrations of SF
produced microtubes with the lowest pore sizes, while the
opposite was observed when increased concentrations of
PEO were used in the blends.
Some works describe the production of patterned MNs
for drug delivery applications. In one case, silk/polyacrylic
acid (PAA) pyramidal composite arrays of MNs, bearing
encapsulatedcompound ineitherPAApedestals, or silk tips,
were made. A rapid initial release was detected from PAA
base part of the MN, yet the silk cone showed slow/
sustained release over time.[211] Another example con-
stitutes slender, normal, and bullet typeMNs, whose forms
were dictated by the casting mold geometry. The mechan-
ical properties ofMNswere enhancedbyMeOHapplication
and bullet shaping.[212] Finally, the silk-based MN patches
of varyingdimensions, tipdiameter, base, and coneangle of
the individual needles have been prepared. Themechanical
properties of the MNs can be adjusted by post-fabrication
vapor-annealing or by loading the needles with silk
microparticles. The microparticles, in turn, were prepared
with silk and PVA using a phase separation method.[213]
Particles of different sizes and shapes can either be
produced by milling, emulsification, laminar jet break-up,
or sonication. If milling is used, degummed SF is chopped,
the chopped snippets are thenwetmilled and the obtained
silk slurry is spray-dried to recover the silk powder.[214]m www.MaterialsViews.com
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www.mme-journal.deDeviations from the stated method exist, resulting in
particles with different properties. For instance, milling
may reduce intermolecular b-sheet stacking and cause
some decrease in MW of fibroin without changing the
intramolecular binding energy. Rough morphology and
the ultrafine particle size result in the increased enzymatic
degradation, as compared to raw fibers.[215] Particles
obtained by attritor–bead mill combination with alkaline
charge repulsion and surfactant repulsion methods pos-
sessed an evidence of amorphous content reduction,
increase in surface area, and also reduction in crystal-
linity.[216] Alternatively, particles can be formulated using
an emulsion method with PVA as emulsifier. Here, an
intermediate step, involving SF/PVAfilmproduction andSF
particles acquisition by PVA extraction, was taken.[217]
Laminar jet break-up and sonication approaches were
previously discussed in the last paragraph of Section 3.1.
Scaffolds, whether planar or 3D, are fabricated through-
out several methods, of which the most common ones are
freeze-drying and salt-leaching. Only few examples among
many are currently presented. Some works report on
electrospinning for hydrophilic and biodegradable planar
devices of SF/PLGA[218] or hybrid salt-leached porous
scaffolds on solid film support.[219] An interesting improve-
ment of the lyophilization-based method was recently
presented in a group of works.[80,220,221] Prior to lyophiliza-
tion,RSFsolutionsare let toslowlyself-assemble inaqueous
media without any additional cross-linkers or (potentially
toxic) solvents. In some cases, a repeated drying–dissolving
process is invoked, where a series of casting, drying, and
re-dissolution of SF material is made, followed by a final
freeze-drying step.[220] The fibroin rearrangements during
the liquid phases, preceding final formulation, result in a
more soluble silk nanofiber formation without dense,
hydrophobic silk II transition. The latter fact has a positive
impact on biocompatibility, mechanical properties (soft-
ness), and improved cell growth and differentiation
behavior. Later treatments of the lyophilized materials,
such as gradient water/MeOH annealing, may be used
to control additional secondary structures, mechanical
properties, and degradation of the scaffolds. Yet, another
way to decrease the unwanted SF conformation transition
from random coil to b-sheet stacking can be achieved
by blending hyaluronan with silk.[222] All of the above
approaches improve SF applicability in tissue engineering
applications.5. Conclusion
Of the various steps in fibroin processing, several do have a
‘‘multiple-choice’’ option of achieving the desired goal. Let
us briefly state the most plausible options for some key
stages of the processing.Macromol. Mater. Eng.
 2015 WILEY-VCH Verlag Gmwww.MaterialsViews.comAprimarydegumming stepof rawmaterial is commonly
done by boiling in alkaline media (Section 2.1). The process
demonstrates good yields and repeatability, however, it
partially damages (degrades) the fibroin that can be
unwanted. For that, using a cocoonase with no effect on
a fiber looks a more promising method.
SF dissolution routine type is dictated by the subsequent
step(s) in the workflow, so that no specific preference
for any of the enumerated methods can be outlined
(Section 2.3). For aqueous SF solutions, near-saturated
bromides and or thiocyanates are typically used. The main
drawback of aqueous solutions is that they need to be
dialyzed, and after the salt removal such solutions are
unstable, rendering long-term storage of the material very
hard. Silk concentration and/or storage temperature of the
aqueous solution play pivotal roles in silk stability within
that solution.
Lyophilization or freeze-drying is by all means an
important step in SF processing chain. Being a purely
physical phenomenon, it can be used in a final step of silk
‘‘activation’’ prior to its re-dissolution, or serve a final goal
per se, as a method of formulation (Section 2.4). Other
techniques of similar type, commonly employed for their
simplicity, are LBL deposition, solvent casting, and
gelation (Sections 2.4–2.5). Gelation and crystallinity
induction are mechanistically close phenomena, and
can both be controlled by same factors of temperature,
shear stress, or additives introduced to SF while still being
in a liquid phase. Since gelation outcomes (morphology,
crystallinity degree, mechanical properties) are controlled
by many factors, it is up to the researcher to choose the
most appropriate method. For instance, Ca2þ comparing
to Kþ at the same concentrations induces a slower
gelation, poloxamer-blended SF of the same concentra-
tion gelated much faster than its PEG-blended counter-
part. Invariantly, the gelation was facilitated by
increasing SF content and/or ambient temperature. For
the maximal crystallinity induction, soaking in methanol
is probably one of the best ways, yet it results in
hazardous methanol waste.
Coupling processes, based on carbodiimide-derived
chemistry, constitute the most significant part of the
literature describing SF enhancement by grafting. It is a
well-established method with the known advantages and
pitfalls. The more recent ‘‘click chemistry’’ approach seems
to be free of safety concerns that substantially challenge
carbodiimide-based reactions (Section 3.1); however, it is
more costly.
Sonochemistry is another completely different, but
valuable tool in SF-based product formulation and entrap-
ping the compounds of interest within silk (Section 3.1) for
their furthercontrolleddelivery.Unfortunately, thismethod
exerts harsh preparation conditions that could be detri-
mental to sensitive molecules intended for incorporation.2015, 12, 1199–1216
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1212High temperatures and shear stresses elicit denaturing
conditions for protein therapeutics. Therefore, when the
desired compound possesses known liability, laminar jet
break-up, water-in-oil emulsion solvent diffusion, desolva-
tion/coacervation, or other mild-conditioned methods are
preferable (some are reviewed in ref.[223]).
Enzymatic approaches constitute a separate Section 3.2.
From variety of the listed possibilities, of processing
significance are the enzymes for (selective) degradation
andgrafting. In thefirst case, controlleddegradationmaybe
used for fine tuning of the formed structure in a treated
material, or for recycling sericultural wastes. In the second
case, enzymatic grafting of molecules via modified Tyr
residue is worth noticing, due to its even distribution
within SF heavy chain sequence.
The current review presented the hallmark of the major
processing options of SF for the laboratory scale. It stands to
reason thatdifferent routines canbe successfully combined
topursueparticular researchgoals. It seems that traditional
chemical approaches still dominate over the ‘‘green
chemistry;’’ however, the significant direction toward
environmentally friendly methods has been constantly
developing. ‘‘Green chemistry’’ reagents alongwithnatural
catalysts (enzymes) started to gain wider acknowledge-
ment in the last decades. Despite the fact that over-
whelming amount of the enzymes is still far from being as
available and effective as traditional chemical techniques,
further improvements of their properties (stability, diver-
sified consensus sequences, availability) will aid in solving
the aforementioned issues in the future.Abbreviations
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